Contemporary challenges of catheter ablation for atrial fibrillation.
Identifieur interne : 003504 ( PubMed/Corpus ); précédent : 003503; suivant : 003505Contemporary challenges of catheter ablation for atrial fibrillation.
Auteurs : Rukshen Weerasooriya ; Ashok J. Shah ; Meleze Hocini ; Pierre Jaïs ; Michel HaïssaguerreSource :
- Clinical therapeutics [ 1879-114X ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical , analysis : Adenosine.
- methods : Catheter Ablation.
- pathology : Heart Atria.
- physiopathology : Atrial Fibrillation.
- surgery : Atrial Fibrillation.
- Electrophysiologic Techniques, Cardiac, Fibrosis, Humans, Patient Selection, Pulmonary Veins, Treatment Outcome.
Abstract
Catheter ablation of atrial fibrillation (AF) is now one of the most frequently performed ablation procedures, but there are currently 2 important challenges: achieving permanent/durable rather than transient pulmonary vein isolation (PVI) and improving the results of ablation for the wider patient population with persistent AF.
DOI: 10.1016/j.clinthera.2014.07.014
PubMed: 25189853
Links to Exploration step
pubmed:25189853Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Contemporary challenges of catheter ablation for atrial fibrillation.</title><author><name sortKey="Weerasooriya, Rukshen" sort="Weerasooriya, Rukshen" uniqKey="Weerasooriya R" first="Rukshen" last="Weerasooriya">Rukshen Weerasooriya</name><affiliation><nlm:affiliation>University of Western Australia, Crawley, Royal Perth Hospital, Perth, Hollywood Private Hospital, Nedlands, Western Australia, Australia. Electronic address: rukshen@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Shah, Ashok J" sort="Shah, Ashok J" uniqKey="Shah A" first="Ashok J" last="Shah">Ashok J. Shah</name><affiliation><nlm:affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</nlm:affiliation></affiliation></author><author><name sortKey="Hocini, Meleze" sort="Hocini, Meleze" uniqKey="Hocini M" first="Meleze" last="Hocini">Meleze Hocini</name><affiliation><nlm:affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</nlm:affiliation></affiliation></author><author><name sortKey="Jais, Pierre" sort="Jais, Pierre" uniqKey="Jais P" first="Pierre" last="Jaïs">Pierre Jaïs</name><affiliation><nlm:affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</nlm:affiliation></affiliation></author><author><name sortKey="Haissaguerre, Michel" sort="Haissaguerre, Michel" uniqKey="Haissaguerre M" first="Michel" last="Haïssaguerre">Michel Haïssaguerre</name><affiliation><nlm:affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25189853</idno><idno type="pmid">25189853</idno><idno type="doi">10.1016/j.clinthera.2014.07.014</idno><idno type="wicri:Area/PubMed/Corpus">003504</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003504</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Contemporary challenges of catheter ablation for atrial fibrillation.</title><author><name sortKey="Weerasooriya, Rukshen" sort="Weerasooriya, Rukshen" uniqKey="Weerasooriya R" first="Rukshen" last="Weerasooriya">Rukshen Weerasooriya</name><affiliation><nlm:affiliation>University of Western Australia, Crawley, Royal Perth Hospital, Perth, Hollywood Private Hospital, Nedlands, Western Australia, Australia. Electronic address: rukshen@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Shah, Ashok J" sort="Shah, Ashok J" uniqKey="Shah A" first="Ashok J" last="Shah">Ashok J. Shah</name><affiliation><nlm:affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</nlm:affiliation></affiliation></author><author><name sortKey="Hocini, Meleze" sort="Hocini, Meleze" uniqKey="Hocini M" first="Meleze" last="Hocini">Meleze Hocini</name><affiliation><nlm:affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</nlm:affiliation></affiliation></author><author><name sortKey="Jais, Pierre" sort="Jais, Pierre" uniqKey="Jais P" first="Pierre" last="Jaïs">Pierre Jaïs</name><affiliation><nlm:affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</nlm:affiliation></affiliation></author><author><name sortKey="Haissaguerre, Michel" sort="Haissaguerre, Michel" uniqKey="Haissaguerre M" first="Michel" last="Haïssaguerre">Michel Haïssaguerre</name><affiliation><nlm:affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Clinical therapeutics</title><idno type="eISSN">1879-114X</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine (analysis)</term><term>Atrial Fibrillation (physiopathology)</term><term>Atrial Fibrillation (surgery)</term><term>Catheter Ablation (methods)</term><term>Electrophysiologic Techniques, Cardiac</term><term>Fibrosis</term><term>Heart Atria (pathology)</term><term>Humans</term><term>Patient Selection</term><term>Pulmonary Veins</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Adenosine</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Catheter Ablation</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Heart Atria</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Atrial Fibrillation</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Atrial Fibrillation</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Electrophysiologic Techniques, Cardiac</term><term>Fibrosis</term><term>Humans</term><term>Patient Selection</term><term>Pulmonary Veins</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Catheter ablation of atrial fibrillation (AF) is now one of the most frequently performed ablation procedures, but there are currently 2 important challenges: achieving permanent/durable rather than transient pulmonary vein isolation (PVI) and improving the results of ablation for the wider patient population with persistent AF.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25189853</PMID><DateCreated><Year>2014</Year><Month>09</Month><Day>19</Day></DateCreated><DateCompleted><Year>2016</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2014</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-114X</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>9</Issue><PubDate><Year>2014</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Clinical therapeutics</Title><ISOAbbreviation>Clin Ther</ISOAbbreviation></Journal><ArticleTitle>Contemporary challenges of catheter ablation for atrial fibrillation.</ArticleTitle><Pagination><MedlinePgn>1145-50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinthera.2014.07.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0149-2918(14)00454-8</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Catheter ablation of atrial fibrillation (AF) is now one of the most frequently performed ablation procedures, but there are currently 2 important challenges: achieving permanent/durable rather than transient pulmonary vein isolation (PVI) and improving the results of ablation for the wider patient population with persistent AF.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Recent technical advances in the technique of ablation and the results of clinical trials aimed at achieving more permanent and durable PVI are reviewed. We also summarize recent advances in identifying atrial fibrosis and in understanding the pathophysiology of AF relevant to selecting patients for ablation of persistent AF.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The use of contact force-sensing technology, adenosine testing after ablation, and pace capture-guided ablation all have the potential for achieving more durable ablation. Selection of patients suitable for ablation of persistent AF may be improved by assessing the extent of atrial fibrosis with delayed enhancement imaging with cardiac magnetic resonance or by assessing the pattern of atrial electrical activity with the use of complex atrial electrograms. Advances in treatment are likely to result from the recognition of localized rotors and focal sources as primary sustaining mechanisms for all types of human AF and in the use of noninvasive mapping for their identification. Linear ablation to supplement PVI may improve the results of AF ablation.</AbstractText><AbstractText Label="IMPLICATIONS" NlmCategory="CONCLUSIONS">Rapidly unfolding advances in the techniques of AF ablation and the understanding of mechanisms of AF hold promise for improving the durability of PVI and for extending the technique to carefully selected patients with persistent AF.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier HS Journals, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weerasooriya</LastName><ForeName>Rukshen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Western Australia, Crawley, Royal Perth Hospital, Perth, Hollywood Private Hospital, Nedlands, Western Australia, Australia. Electronic address: rukshen@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ashok J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hocini</LastName><ForeName>Meleze</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaïs</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haïssaguerre</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Bordeaux, Bordeaux, Hôpital Cardiologique du Haut-Leveque, Pessac, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Ther</MedlineTA><NlmUniqueID>7706726</NlmUniqueID><ISSNLinking>0149-2918</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>K72T3FS567</RegistryNumber><NameOfSubstance UI="D000241">Adenosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000241" MajorTopicYN="N">Adenosine</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022062" MajorTopicYN="N">Electrophysiologic Techniques, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006325" MajorTopicYN="N">Heart Atria</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011667" MajorTopicYN="N">Pulmonary Veins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmia</Keyword><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">catheter ablation</Keyword><Keyword MajorTopicYN="N">review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>06</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>07</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25189853</ArticleId><ArticleId IdType="pii">S0149-2918(14)00454-8</ArticleId><ArticleId IdType="doi">10.1016/j.clinthera.2014.07.014</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003504 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003504 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25189853
|texte= Contemporary challenges of catheter ablation for atrial fibrillation.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25189853" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |